In a major policy shift, federal health officials anticipate the shots will be made available to adults 65 and older as well as children and younger adults who have one or more risk factors that make them more vulnerable to severe COVID-19.

"Here is a prime example of just how influential Big Pharma still is," MAHA influencer Diana Atieh told Newsweek.

COVID-19 shots for healthy younger adults and children will no longer be routinely approved under a major new policy shift unveiled Tuesday by the Trump administration. Top officials for the Food and Drug Administration laid out new requirements for yearly updates to COVID shots,

FDA officials outlined new restrictions for COVID-19 vaccine approvals in the United States that could limit their use among healthy people.

Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental The U.S. Food and Drug Administration (FDA) has officially approved a COVID-19 vaccine from Novavax for adults 65 and older and for individuals ages 12 to 64 who have an underlying health condition that puts them at higher risk for serious illness from a coronavirus infection.

Changes are on the way for COVID vaccines after the FDA adjusted the standard of evidence needed to approve shots for the general public.

The Trump administration plans to drop routine COVID vaccination guidance for kids and pregnant women, marking a major shift in federal health policy, according to a report.

Kennedy Jr. plans to remove CDC recommendations for COVID-19 vaccination in pregnant women and children. Come the fall, it may just be older adults and people with comorbidities who are urged to get a COVID shot.